DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (89)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 89   Next >>

Possible Epirubicin side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20

Patient:

Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: arm b
    Administration route: Oral
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer

Lapatinib
    Dosage: arm c
    Administration route: Oral

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer

Herceptin
    Dosage: maintenance dose

Fluorouracil
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer



Possible Epirubicin side effects in female

Reported by a physician from Netherlands on 2012-07-30

Patient: female, weighing 61.5 kg (135.3 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
NO Treatment Received
    Dosage: no treatment received
    Indication: Breast Cancer

Epirubicin
    Dosage: 177 mg, unk
    Indication: Breast Cancer
    Start date: 2011-03-22

Fluorouracil
    Dosage: 885 mg, unk
    Indication: Breast Cancer
    Start date: 2011-03-22

Cyclophosphamide
    Dosage: 885 mg, unk
    Indication: Breast Cancer
    Start date: 2011-03-22

Other drugs received by patient: Granisetron



Possible Epirubicin side effects in 57 year old female

Reported by a consumer/non-health professional from Spain on 2012-07-27

Patient: 57 year old female

Reactions: Pyrexia, Neutropenia, Hidradenitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2006-08-23
    End date: 2006-11-02

Docetaxel
    Indication: Breast Cancer
    Start date: 2006-08-23
    End date: 2006-11-02

Other drugs received by patient: Hipoartel; Simvastatin; Ceftazidime; Pantoprazole



Possible Epirubicin side effects in 58 year old female

Reported by a physician from Taiwan, Province of China on 2012-07-24

Patient: 58 year old female, weighing 57.3 kg (126.1 pounds)

Reactions: Multi-Organ Failure, Pneumonia, Coagulopathy, Central Nervous System Lesion, Acute Respiratory Distress Syndrome, Neutropenia, Acute Respiratory Failure, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Start date: 2010-12-28
    End date: 2010-12-28

Taxotere
    Indication: Breast Cancer
    Start date: 2010-09-30
    End date: 2010-09-30

Taxotere
    Start date: 2010-12-28
    End date: 2010-12-28

Epirubicin
    Indication: Breast Cancer
    Start date: 2010-09-30
    End date: 2010-09-30

Other drugs received by patient: Granocyte



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23

Patient: female, weighing 61.2 kg (134.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-30

Epirubicin
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-02
    End date: 2009-12-02

Fluorouracil
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-02
    End date: 2009-12-02

Fluorouracil
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-30

Cyclophosphamide
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-02
    End date: 2009-12-02

Cyclophosphamide
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-30



Possible Epirubicin side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-07-23

Patient: 65 year old female, weighing 51.8 kg (114.0 pounds)

Reactions: Acinetobacter Infection, Postoperative Wound Infection, Postoperative Wound Complication, Wound Infection Staphylococcal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluorouracil
    Dosage: df, every three weeks intravenous, df, every three weeks intravenous
    Indication: Breast Cancer
    Start date: 2010-08-07
    End date: 2010-08-07

Fluorouracil
    Dosage: df, every three weeks intravenous, df, every three weeks intravenous
    Indication: Breast Cancer
    Start date: 2010-09-09

Cyclophosphamide
    Dosage: df, every three weeks intravenous, df, every three weeks intravenous
    Start date: 2010-08-07

Cyclophosphamide
    Dosage: df, every three weeks intravenous, df, every three weeks intravenous
    Start date: 2010-09-09

Epirubicin
    Dosage: df, every three weeks intravenous, df, every three weeks intravenous
    Indication: Breast Cancer
    Start date: 2010-09-09

Epirubicin
    Dosage: df, every three weeks intravenous, df, every three weeks intravenous
    Indication: Breast Cancer
    Start date: 2010-08-07
    End date: 2010-08-07

Other drugs received by patient: Granisetron; Dexamethasone; Lamivudine; Metoclopramide Hydrochloride



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23

Patient: female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-01-05
    End date: 2011-01-05

Cyclophosphamide
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-02-16
    End date: 2011-02-16

Cyclophosphamide
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2010-12-08

Fluorouracil
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-01-05
    End date: 2011-01-05

Fluorouracil
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-02-16
    End date: 2011-02-16

Fluorouracil
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2010-12-08

Epirubicin
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-02-16
    End date: 2011-02-16

Epirubicin
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2010-12-08

Epirubicin
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-01-05
    End date: 2011-01-05

Other drugs received by patient: Dexamethasone; Ondansetron



Possible Epirubicin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23

Patient: 48 year old female

Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06

Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-06

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-27

Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23

Patient: female

Reactions: Diarrhoea, Chills, Febrile Neutropenia, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: every cycle
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2011-01-05

Cyclophosphamide
    Dosage: every cycle
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2011-01-05

Fluorouracil
    Dosage: every cycle
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2011-01-05

Other drugs received by patient: Dexamethasone; Onsia



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-20

Patient: female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2009-10-29
    End date: 2009-10-29

Cyclophosphamide
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2010-01-04
    End date: 2010-01-04

Fluorouracil
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2010-01-04
    End date: 2010-01-04

Fluorouracil
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2009-10-29
    End date: 2009-10-29

Epirubicin
    Dosage: (150 mg; every cycle), (150 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2010-01-04
    End date: 2010-01-04

Epirubicin
    Dosage: (150 mg; every cycle), (150 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2009-10-29
    End date: 2009-10-29

Other drugs received by patient: Ondansetron; Lenograstim; Dexamethasone



Possible Epirubicin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20

Patient: 63 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30

Cyclophosphamide
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30

Fluorouracil
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30



Possible Epirubicin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20

Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)

Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Epirubicin
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Taxotere
    Dosage: 4 cycles, total 3 courses, dose taken once daily
    Indication: Breast Cancer
    Start date: 2011-10-14
    End date: 2011-11-25

Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S



Possible Epirubicin side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20

Patient: 58 year old female

Reactions: Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: (df; every three weeks intravenous drip), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-08-04
    End date: 2010-08-04

Fluorouracil
    Dosage: (df; every three weeks intravenous drip), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-08-04
    End date: 2010-08-04

Cyclophosphamide
    Dosage: (df; every three weeks intravenous drip), (df; dose reduced intravenous drip)
    Indication: Breast Cancer
    Start date: 2010-08-04
    End date: 2010-08-04



Possible Epirubicin side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20

Patient: 62 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: (df), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-07-23
    End date: 2010-07-23

Fluorouracil
    Dosage: (df), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-07-23
    End date: 2010-07-23

Cyclophosphamide
    Dosage: (df), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-07-23
    End date: 2010-07-23



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-09

Patient: female

Reactions: Drug Intolerance, Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Neoplasm
    Start date: 2011-08-01

Cyclophosphamide
    Dosage: 14 days on 21 days
    Start date: 2011-02-01
    End date: 2011-07-01

Doxorubicin HCL
    Dosage: 9 courses
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-02-19
    End date: 2009-11-05

Taxotere
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-03-08
    End date: 2005-04-19

Doxorubicin HCL
    Dosage: 8 courses
    Start date: 2007-11-27
    End date: 2008-06-24

Cyclophosphamide
    Start date: 2004-12-03
    End date: 2005-02-02

Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2004-12-03
    End date: 2005-02-02

Epirubicin
    Indication: Product Used FOR Unknown Indication
    Start date: 2004-12-03
    End date: 2005-02-02

Other drugs received by patient: Aromasin; Navoban; Xeloda; Faslodex; Estracyt; Femara; Arimidex; Navelbine



Possible Epirubicin side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15

Patient: male

Reactions: Metastases To Adrenals, Neuroblastoma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Start date: 2007-01-01
    End date: 2007-01-01

Cyclophosphamide
    Start date: 2007-01-01
    End date: 2007-01-01

Fluorouracil
    Start date: 2007-01-01
    End date: 2007-01-01



Possible Epirubicin side effects in female

Reported by a individual with unspecified qualification from Germany on 2012-06-07

Patient: female

Reactions: Vomiting, Nausea, Inappropriate Antidiuretic Hormone Secretion, Coma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2012-04-16
    End date: 2012-04-16

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-04-16
    End date: 2012-04-16

Other drugs received by patient: Prednisone TAB; Dexamethasone; Sodium Chloride; Aprepitant; Mesna; Granisetron; Hydroxychloroquine Sulfate



Possible Epirubicin side effects in 69 year old female

Reported by a consumer/non-health professional from France on 2012-05-31

Patient: 69 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Malaise, Hyperthermia, Febrile Bone Marrow Aplasia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 100 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2012-03-29

Fluorouracil
    Dosage: 500 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2012-03-29

Cyclophosphamide
    Dosage: 100 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2012-03-29

Neulasta
    Dosage: 6 mg, one time dose
    Indication: Chemotherapy
    Start date: 2012-03-30
    End date: 2012-03-30

Other drugs received by patient: Motilium / 00498201 /



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30

Patient: 49 year old female

Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Vincristine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cyclophosphamide
    Dosage: 100 mg
    Administration route: Oral
    Indication: Anaemia

Prednisolone
    Indication: Leukocytosis

Fluorouracil
    Indication: Breast Cancer

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cyclophosphamide
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Leukocytosis
    Start date: 2009-07-01

Epirubicin
    Indication: Breast Cancer

Prednisolone
    Dosage: 15 mg
    Indication: Anaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-25

Patient: 49 year old female

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II

Fluorouracil
    Indication: Breast Cancer Stage II

Epirubicin
    Indication: Breast Cancer Stage II



Possible Epirubicin side effects in male

Reported by a consumer/non-health professional from China on 2012-05-24

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Off Label Use, Rash Erythematous, Gastric Cancer

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluorouracil
    Indication: Gastric Cancer Stage III

Doxorubicin HCL
    Indication: Gastric Cancer Stage III

Doxorubicin HCL
    Start date: 2011-10-30
    End date: 2011-11-02

Doxorubicin HCL

Epirubicin
    Indication: Gastric Cancer Stage III

Cytoxan
    Indication: Gastric Cancer Stage III



Possible Epirubicin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22

Patient: 44 year old female

Reactions: Atrial Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluorouracil
    Dosage: 3 cycles.
    Indication: Breast Cancer

Epirubicin
    Dosage: 3 cycles.
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: 3 cycles.
    Indication: Breast Cancer

Taxotere
    Dosage: 3 cycles.
    Indication: Breast Cancer

Trastuzumab
    Dosage: 3 cycles.
    Indication: Breast Cancer
    Start date: 2009-01-01
    End date: 2010-07-06

Other drugs received by patient: Amlodipine Besylate



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-22

Patient: 49 year old female

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer Stage II

Cytoxan
    Indication: Breast Cancer Stage II

Fluorouracil
    Indication: Breast Cancer Stage II



Possible Epirubicin side effects in 70 year old female

Reported by a physician from Germany on 2012-05-21

Patient: 70 year old female, weighing 67.0 kg (147.4 pounds)

Reactions: Arrhythmia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluorouracil
    Dosage: 868 mg, qd

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Prophylaxis
    Start date: 2012-01-25

Cytoxan
    Dosage: 868 mg, qd

Epirubicin
    Dosage: 174 mg, qd

Other drugs received by patient: Dexamethasone; Mesna; Docetaxel; ACE Inhibitors; Aloxi; Fosaprepitant Dimeglumine; Insulin



Possible Epirubicin side effects in 67 year old male

Reported by a consumer/non-health professional from United Kingdom on 2012-05-18

Patient: 67 year old male, weighing 85.0 kg (187.0 pounds)

Reactions: Gastrointestinal Anastomotic Leak, Post Procedural Haemorrhage

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Capecitabine
    Dosage: 5250 mg, unk
    Administration route: Oral
    Start date: 2011-12-08

Cisplatin
    Dosage: unk
    Indication: Gastric Cancer
    Start date: 2011-09-22

Bevacizumab
    Dosage: 655 mg, unk
    Start date: 2011-11-17

Capecitabine
    Dosage: unk
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-09-22

Cisplatin
    Dosage: 120 mg, unk
    Start date: 2011-11-17

Epirubicin
    Dosage: unk
    Indication: Gastric Cancer
    Start date: 2011-09-22

Bevacizumab
    Dosage: unk
    Indication: Gastric Cancer
    Start date: 2011-09-22

Epirubicin
    Dosage: 50 mg, unk
    Start date: 2011-11-17



Possible Epirubicin side effects in female

Reported by a physician from Germany on 2012-05-18

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Vomiting, Nasopharyngitis, Nausea, Diarrhoea, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 200 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

NO Treatment Received
    Dosage: no treatment
    Indication: Breast Cancer

Fluorouracil
    Dosage: 100 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

Cyclophosphamide
    Dosage: 1000 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

Other drugs received by patient: Paracodin Bitartrate TAB; Cefuroxime; Acetylcysteine; Allopurinol



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytoxan
    Dosage: 100 mg, unk
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 44 year old female

Reported by a physician from France on 2012-05-17

Patient: 44 year old female

Reactions: Atrial Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    End date: 2010-07-06

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer

Taxotere
    Indication: Breast Cancer

Other drugs received by patient: Amlodipine Besylate



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-09

Patient: 67 year old male

Reactions: Liver Abscess

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
TSU-68
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2012-03-16
    End date: 2012-03-19

Epirubicin
    Indication: Hepatic Neoplasm Malignant
    Start date: 2012-03-06

Other drugs received by patient: Metilon; Glycyron / 00466401 /; Zolpidem; Rabeprazole Sodium; Ursodiol



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012